Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ FN3K Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA566239

Catalog No. PIPA566239


Only null left
Add to Cart

Description

Description

Immunogen sequence: KLKEEENTVGR RGEGAEPQYV DKFGFHTVTC CGFIPQVNEW QDDWPTFFAR HRLQAQLDLI EKDYADREAR E Highest antigen sequence identity to the following orthologs - mouse 82%, rat 81%.

FN3K catalyzes phosphorylation of fructosamines formed by glycation, the nonenzymatic reaction of glucose with primary amines followed by Amadori rearrangement. Phosphorylation of fructosamines may initiate metabolism of the modified amine and result in deglycation of glycated proteins.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

FN3K
Polyclonal
Unconjugated
Fn3k
2310074G21Rik; FN3K; Fnsk; fructosamine 3 kinase; fructosamine 3-kinase; fructosamine-3-kinase; Protein-psicosamine 3-kinase FN3K; Protein-ribulosamine 3-kinase FN3K
Rabbit
Antigen Affinity Chromatography
RUO
64122
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Immunocytochemistry
0.05 mg/mL
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2
Q9H479
Fn3k
Recombinant Human FN3K. Recombinant protein control fragment (Product #RP-106920).
100 μL
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.